Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka) Profile
Key Indicators
- Authorised Capital ₹ 35.00 Cr
- Paid Up Capital ₹ 15.48 Cr
- Company Age 43 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth 15.58%
- Ebitda 15.58%
- Net Worth 0.39%
- Total Assets 0.19%
About Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka)
Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka) Limited (SFCAPAKL) is a Public Limited Indian Non-Government Company incorporated in India on 24 July 1981 and has a history of 43 years and six months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 35.00 Cr and a paid-up capital of Rs 15.48 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka) Limited India are Adarsha Tadisetty as CFO and Mahalakshmi Chivukula as Company Secretary. Gwori Thirupathi, Jagadeesh Pilli, and Gopi Repala serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299KA1981PLC004321
-
Company No.
004321
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
24 Jul 1981
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka)?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Adarsha Tadisetty | CFO | 05-Apr-2024 | Current |
Mahalakshmi Chivukula | Company Secretary | 03-Apr-2024 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gwori Thirupathi | Director | 29-Mar-2024 | Current |
Jagadeesh Pilli | Additional Director | 05-Apr-2024 | Current |
Gopi Repala | Director | 29-Mar-2024 | Current |
Financial Performance of Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka).
Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka) Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 15.58% increase in profit. The company's net worth moved up by a moderate rise of 0.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka)?
In 2022, Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka)?
Unlock and access historical data on people associated with Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shrishma Fine Chemicals And Pharmaceutic Als (Karnataka)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.